Evistaand/or alternativesChemical Ingredient: Raloxifene Hydrochloride
What is a generic medication?
Generic medications are significantly discounted copies of brand name medication that have the same active ingredients, intended use, dosage, side effects, effects, and route of administration as the original brand name medication. In other words, generic medications have the same pharmacological effects as their brand-name counterparts. Over half of all prescribed medications are for generic medications.
- Manufactured by Daiichi Sankyo Inc
- Product of Turkey • Shipped from Turkey
- Prescription Required
- Manufactured by An MHRA approved UK Generic Manufacturer
- Product of United Kingdom • Shipped from United Kingdom
- Prescription Required
Evista Helps Treat the Following Conditions:
Osteoporosis in postmenopausal women
Osteoporosis is a condition which threatens many post-menopausal women. It is characterized by the thinning of bones caused by lack of the primary female sex hormone, estrogen. Evista works like estrogen in the bones and helps to stop bone loss.
Invasive breast cancer in postmenopausal women
Recent studies have suggested an ability for raloxifene, the active ingredient in Evista, to kill some human cancer cells. Still, Evista has so far only been used for breast cancer prevention in healthy menopausal women. It is prescribed to lower chances of a certain type of invasive breast cancer in high-risk patients.
Generic Alternatives to Evista
The active ingredient is Evista is called raloxifene. It belongs to a class of drugs known as selective estrogen receptor modulators or SERMs. It mimics estrogen the female sex hormone in some parts of the body, like the bones. Raloxifene’s estrogen-like effect helps to maintain healthy bone density. Generic alternatives to Evista contain raloxifene as the active ingredient.
Patients can get safe, affordable generic alternatives to Evista through our international online pharmacy.
Evista in the News
Raloxifene Blunts Symptoms in Women With Schizophrenia
Raloxifene, the active ingredient in the osteoporosis drug Evista, reduced illness severity in women with refractory schizophrenia, researchers from Monash University in Melbourne, Australia have reported.
"This large trial of raloxifene in this patient population offers a promising, well-tolerated agent that has potential application in clinical practice," researchers have written.
Unlike regular estrogen therapy, raloxifene exerts estrogenic effects on the brain but acts as an estrogen antagonist in breast and ovarian tissue.
Osteoporosis drug may treat breast and liver cancers
A drug used to prevent and treat osteoporosis in post-menopausal women may also be able to treat some breast and liver cancers, according to a new study from Oregon State University.
Although clinical trials on patients are still needed, in lab tests, researchers have found that the substance raloxifene kills human liver cancer cells as well as breast cancer cells that are "triple-negative”.
Triple-negative breast cancers represent up to 20 percent of all breast cancers in the United States and are more common in younger and African-American women. Chemotherapy, radiation and surgery are the preferred treatments because triple-negative breast cancers do not respond to breast cancer medications like Tamoxifen or Trastuzumab.
Evista General Information
Evista slows down bones loss and is prescribed to reduce the risk of osteoporosis in post-menopausal women. It belongs to a class of drugs known as selective estrogen receptor modulators and acts like the female sexual hormone estrogen in bones and like an estrogen blocker in the uterus and breasts.
This medicine should not be used before menopause. It is also not suitable for relieving menopausal symptoms like hot flashes, or for preventing heart disease.
Besides helping to prevent bone loss, Evista may also lower the chance of invasive breast cancer after menopause.
In some rare cases, Evista may cause blood clots, especially in the lungs and legs. Women with a history of blood clots, particularly in the legs, lungs or eyes should not take this medication.
Evista is also not suitable for women who have had a heart attack or are at risk. In such patients, Evista can increase the risk of fatal strokes.
Before starting treatment, women need to discuss their full medical history with their doctor. This includes any history of blood clots, mini-stroke, heart disease, heart attack or atrial fibrillation – a type of irregular heartbeat. Women with high cholesterol and high blood pressure as well as female smokers should also discuss the risks and benefits of Evista treatment with their doctor.
The information on this page is not a replacement for a consultation with a physician, qualified to treat this condition and prescribe medication. The information is supplied by a third party, independent from this website and only serves to raise awareness about this condition and point out basic information regarding treatment.
The website cannot take responsibility for the reliability or medical efficacy of the information provided. As mentioned above, patients should seek medical attention to ensure effective and safe treatment.
Not all products are shipped by our contracted Canadian pharmacy. The source country, shipping country or drug manufacturer may vary depending on availability.
The website also maintains commercial ties with dispensaries around the world. Products can be sourced from a number of countries. Patients should note that different items within an order can be shipped from different jurisdictions, depending on availability and cost at the time an order was placed.
How to Use Evista
Patients are usually prescribed Evista once daily. The medication should be taken orally, with or without food.
It is important to take Evista regularly in order to experience its full benefit. It will be easier to remember taking this medication if the daily dose is always taken at the same time.
Patients should make sure they get enough vitamin D, and some may need to take calcium or vitamin D supplements.
Women who are pregnant or are planning to become pregnant should not handle Evista. It is also important to reduce the risk of breathing dust from the tablets. The medication can be absorbed through the skin and lungs and may harm an unborn baby.
Before starting treatment, patients need to discuss the possibility of allergic reactions to Evista.
It is also vital to discuss a patient’s medical history, especially any history of blood clots, mini-stroke, heart disease, heart attack or atrial fibrillation – a type of irregular heartbeat. Smokers, as well as women with high blood pressure and cholesterol, should also alert their doctor before starting this medication. Other pre-existing conditions that need to be mentioned include high triglyceride levels in the blood caused by estrogen treatment, kidney or liver disease, heart failure or cancer.
Lack of movement increases the risk of blood clots, as does taking Evista. Patients need to tell their doctor if they expect to spend long periods of time confined to a bed or chair (eg. post-surgery recovery or a long plane flight). Patients should also mention if they are about to undergo surgery. This medication can harm an unborn baby. It is not known whether Evista passes into breast milk.
Patients who miss a dose of Evista should take it as soon as they remember. If this happens near the time for the next dose, patients should skip the missed dose and proceed as usual. Patients should not double the dose in order to catch up.
Drug interactions may change the way Evista works and can increase the risk of side effects.
Before starting treatment, patients need to discuss the full list of medications and supplements they are taking with their doctor. Patients should not change their dose or stop taking Evista unless their physician advises them to do so.
Evista may interfere with certain laboratory tests. Women who take this medicine need to alert medical personnel about the possibility of Evista interacting test results.
Evista Side Effects
Some women may experience hot flashes in the beginning of treatment. Patients should inform their doctor if their symptoms persist or worsen.
Most postmenopausal women can use this drug safely without serious side effects. Still, patients should monitor for signs of some possible serious side effects such as blood clots. These include sudden pain, swelling, redness or warmth in the leg or arm.
Symptoms of a blood clot in the lungs include chest pain, trouble breathing and coughing up blood. A blood clot in the eyes may cause sudden blurred vision or loss of vision. Patients should also monitor for signs of stroke – weakness on one side of the body, trouble speaking, sudden vision changes and confusion.
Serious allergic reactions to Evista are rare, yet patients should be aware of symptoms such as rash, itching and swelling, severe dizziness and trouble breathing.
Evista should be stored at room temperature away from light or moisture. Do not store in the bathroom. Keep away from children and pets.
Unwanted medication should be disposed of properly and should not be poured into drains or flushed down the toilet. Patients should consult a pharmacist or their local waste disposal company to find out more about safe disposal methods.
Evista Drug Information
Raloxifene is used by women to prevent and treat bone loss (osteoporosis) after menopause. It slows down bone loss and helps to keep bones strong, making them less likely to break. Raloxifene may also lower the chance of getting a certain type of breast cancer (invasive breast cancer) after menopause. Raloxifene is not an estrogen hormone, but it acts like estrogen in some parts of the body, like your bones. In other parts of the body (uterus and breasts), raloxifene acts like an estrogen blocker. It does not relieve menopause symptoms such as hot flashes. Raloxifene belongs to a class of drugs known as selective estrogen receptor modulators-SERMs. Evista should not be used before menopause. It should not be used to prevent heart disease.
Raloxifene may rarely cause serious blood clots, especially in the legs or lungs. Women who have or had blood clots (including in the legs, lungs, or eyes) should not take raloxifene. Also, women who have had a heart attack or are at risk for a heart attack may rarely have an increased risk of dying from a stroke while taking raloxifene. Before starting treatment with raloxifene, tell your doctor if you have or had blood clots in your legs/lungs/eyes, a stroke, mini-stroke (TIA), heart disease, heart attack, high cholesterol, irregular heartbeat called atrial fibrillation, high blood pressure, or if you smoke. Discuss these risks and the benefits of using raloxifene with your doctor.
How to Use Evista
Read the Medication Guide provided by your pharmacist before you start taking raloxifene and each time you get a refill. If you have any questions, ask your doctor or pharmacist. Take Evista by mouth with or without food as directed by your doctor, usually once daily. Take Evista regularly to get the most benefit from it. To help you remember, take it at the same time each day. Be sure to get enough calcium and vitamin D in your diet. Consult your doctor or pharmacist to see if you need to take calcium and vitamin D supplements. Since Evista can be absorbed through the skin and lungs and may harm an unborn baby, women who are pregnant or who may become pregnant should not handle Evista or breathe the dust from the tablets.
Before taking raloxifene, tell your doctor or pharmacist if you are allergic to it, or if you have any other allergies. may contain inactive ingredients, which can cause allergic reactions or other problems. Talk to your pharmacist for more details. Before using Evista, tell your doctor or pharmacist your medical history,blood clots (including in the legs/lungs/eyes), stroke, mini-stroke (TIA), heart disease (blocked blood vessels in the heart), heart attack, high cholesterol, irregular heartbeat called atrial fibrillation, high blood pressure, smoking, kidney disease, liver disease, heart failure, cancer, high blood fat (triglyceride) levels caused by estrogen treatment. Tell your doctor if you just had or will be having surgery or if you will be confined to a bed or chair for a long time (such as a long plane flight). These conditions increase your risk of getting blood clots, especially if you are using raloxifene. You may need to stop Evista for a time or take special precautions. Evista must not be used during pregnancy. It may harm an unborn baby. If you become pregnant or think you may be pregnant, tell your doctor right away. It is unknown if Evista passes into breast milk. Consult your doctor before breast-feeding.
If you miss a dose of Evista, take it as soon as you remember. If it is near the time of the next dose, skip the missed dose. Take your next dose at the regular time. Do not double the dose to catch up.
Drug interactions may change how your medications work or increase your risk for serious side effects. This document does not contain all possible drug interactions. Keep a list of all the products you use (including prescription/nonprescription drugs and herbal products) and share it with your doctor and pharmacist. Do not start, stop, or change the dosage of any medicines without your doctor's approval.bile acid-binding resins (such as cholestyramine, colestipol), estrogens. Evista may interfere with certain laboratory tests, possibly causing false test results. Make sure laboratory personnel and all your doctors know you use Evista.
Evista Side Effects
Hot flashes or leg cramps may occur. If either of these effects persists or worsens, tell your doctor or pharmacist promptly. Remember that your doctor has prescribed Evista because he or she has judged that the benefit to you is greater than the risk of side effects. Many people using Evista do not have serious side effects. Get medical help right away if you have any very serious side effects,signs of a blood clot (such as sudden pain/swelling/redness/warmth in the leg or arm, chest pain, trouble breathing, coughing up blood, sudden vision changes like blurred vision/loss of vision), signs of a stroke (such as weakness on one side of the body, trouble speaking, sudden vision changes, confusion). A very serious allergic reaction to Evista is rare. However, get medical help right away if you notice any symptoms of a serious allergic reaction,rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, trouble breathing. This is not a complete list of possible side effects. If you notice other effects not listed above, contact your doctor or pharmacist. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or at www.fda.gov/medwatch. In Canada - Call your doctor for medical advice about side effects. You may report side effects to Health Canada at 1-866-234-2345.List of Evista side effects
Store at room temperature away from light and moisture. Do not store in the bathroom. Keep all medications away from children and pets. Do not flush medications down the toilet or pour them into a drain unless instructed to do so. Properly discard when it is expired or no longer needed. Consult your pharmacist or local waste disposal company.
IMPORTANT DISCLAIMER: All medical content is supplied by a third party company who is independent from this web site. As such, this web site can not guarantee the reliability, accuracy, and /or medical efficacy of the information provided. In all circumstances, you should seek the advice of a health professional pertaining to drug, treatment and/or medical condition advice. Note that not all products are shipped by our contracted Canadian pharmacy. This website contracts with dispensaries around the world that ship products directly to our customers. Some of the jurisdiction include but are not limited to United Kingdom, Europe, Turkey, India, Canada, Vanuatu, Mauritius, and USA. The items within your order may be shipped from any one of these jurisdiction depending on the availability and cost of the products at the time you place your order. The products are sourced from these countries as well as others. Please note that the product appearance may vary from actual product received depending on availability.